Search
Close this search box.

Terumo Aortic announces launch and first commercial use of the Aortic Balloon device

The device assists physicians in the expansion of the aorta when using TREO and RELAY stent-grafts in endovascular aortic repair. Complementing our market leading product range of surgical and endovascular grafts, the Aortic Balloon is a low profile device with 10 F and offers exceptional inflation control and the broadest balloon diameter range, up to […]

Terumo Creates Global Group Music

The composition is based on the concept “Let’s respect the past, dream for the future, and open new doors together.” The track is composed by Mr. Akira Senju, a highly regarded Japanese composer and recipient of numerous awards and honors. Mr. Senju’s 35th anniversary album which was released on October 21 includes ‘TOGETHER’, one of […]

Terumo Aortic announces US FDA Approval for TREO endovascular device

TREO is the only device commercially available for endovascular aneurysm repair (EVAR) with dual proximal fixation and lock stent technology offering physicians the next advancement in endovascular device solutions. It is a three-piece design featuring in situ limb adjustability and provides a wide range of aortic device configurations to specifically address the anatomy of each […]

Terumo Aortic Announces US FDA Breakthrough Device designation for Thoraflex Hybrid device

The purpose of the FDA’s Breakthrough Device Designation program is to fast-track the regulatory review process for certain medical technologies and device-led combination products that satisfy certain criteria; these include providing a more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions. The aim of the program is to provide patients and […]

Terumo acquires Aortica Corporation

Terumo Corporation (TSE: 4543) today announced that it has decided to acquire Aortica Corporation, a U.S.-based company dedicated to advancing the science of personalised vascular therapy. Aortica has developed an automated case planning software known as AortaFit™, designed to precisely match fenestrations on an endograft with the unique locations of each individual patient’s branch arteries […]

Terumo Aortic announces completion of enrolment of Relay®Pro US pivotal study

RelayPro is a low profile, next generation thoracic stent graft device designed to expand the treatment of thoracic endovascular aortic repair (TEVAR) to patients with smaller access vessels. RelayPro, having obtained CE Mark in 2018, utilises the same stent design, material and dual sheath technology already proven in Terumo Aortic’s Relay®Plus device, with the additional […]

Terumo Aortic announces launch of industry-first global endovascular registry

TiGER is a global, prospective, multi-arm, multi-centre registry evaluating more than 1,000 patients over a period of 5 years. The study will collect a broad range of clinical evidence on the company’s comprehensive thoracic and abdominal endovascular product portfolio. At the recent European Investigators’ Meeting, the TiGER Principal Investigator, Professor Vincent Riambau, Barcelona commented, “This […]

Latest news

Subscribe for Email Updates

Your subscription could not be saved. Please try again.
Please check your email to confirm your subscription.

Subscribe to our regular email news to keep you updated on the latest information and events from Terumo Aortic.

We use Brevo as our marketing platform. By clicking below to submit this form, you acknowledge that the information you provided will be transferred to Brevo for processing in accordance with their terms of use